-
Signature
-
/s/ Andrew Fisher, Attorney-in-fact for Vikas Sinha
-
Stock symbol
-
VRNA
-
Transactions as of
-
Apr 29, 2025
-
Transactions value $
-
-$150,340
-
Form type
-
4
-
Date filed
-
5/1/2025, 08:53 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
VRNA |
Ordinary Shares |
Options Exercise |
$25.6K |
+15K |
+20.21% |
$1.70 |
89.5K |
Apr 29, 2025 |
Direct |
F1 |
| transaction |
VRNA |
Ordinary Shares |
Sale |
-$134K |
-15K |
-16.82% |
$8.92 |
74.4K |
Apr 29, 2025 |
Direct |
F1, F2 |
| transaction |
VRNA |
Ordinary Shares |
Options Exercise |
$2.49K |
+4.95K |
+6.65% |
$0.50 |
79.4K |
Apr 29, 2025 |
Direct |
F1 |
| transaction |
VRNA |
Ordinary Shares |
Sale |
-$44.2K |
-4.95K |
-6.24% |
$8.92 |
74.4K |
Apr 29, 2025 |
Direct |
F1, F2, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
VRNA |
Share Options (Right to Buy) |
Options Exercise |
$0 |
-15K |
-15.68% |
$0.00 |
81K |
Apr 29, 2025 |
Ordinary Shares |
15K |
$1.70 |
Direct |
F4, F5 |
| transaction |
VRNA |
Share Options (Right to Buy) |
Options Exercise |
$0 |
-4.95K |
-2.48% |
$0.00 |
195K |
Apr 29, 2025 |
Ordinary Shares |
4.95K |
$0.50 |
Direct |
F4, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: